The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
bioRxiv Preprint Server March 7, 2021 Urszula Kozłowska, Aleksandra Klimczak, Kalina Wiatr et al. 27 citations preprint
Psychedelics are new, promising candidate molecules for clinical use in psychiatric disorders such as Treatment-Resistant Depression (TRD) and Post Traumatic Stress Disorder (PTSD). They were recently also proposed as molecules supporting neural tissue repair by anti-inflammatory properties. Here we reported that two classic psychedelics, DMT and psilocin, can influence microglial functions by...